OneSkin
OneSkin is a pioneering company in the skincare industry, specializing in science-led topical treatments aimed at enhancing skin longevity. Founded by four Brazilian PhD scientists, the company is known for its innovative approach, including the development of the patented peptide OS-01. This peptide is scientifically proven to reverse the skin's biological age by targeting senescent cells, which are key contributors to aging, thereby promoting healthier and more youthful skin.
Leadership & Board
- Current Number of Employees
- 63
- Current LinkedIn Followers
- 26,815
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $20M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $20M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
OneSkin had 63 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
OneSkin had 26,815 followers as of October 12, 2026. The number of followers increased by 48 (0.18%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series A | $20.00M | ― |
Similar Companies
A snapshot of private companies similar to OneSkin, helping you discover and navigate related company profiles.
Related News and Analysis
